HomeTTI • CVE
add
Thiogenesis Therapeutics Corp
Nakaraang pagsara
$0.57
Sakop ng araw
$0.55 - $0.58
Sakop ng taon
$0.52 - $1.06
Market cap
25.31M CAD
Average na Volume
13.73K
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (CAD) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | — | — |
Gastos sa pagpapatakbo | 677.78K | -38.12% |
Net na kita | -656.86K | 37.71% |
Net profit margin | — | — |
Kita sa bawat share | — | — |
EBITDA | — | — |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (CAD) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 4.15M | 14.19% |
Kabuuang asset | 4.25M | 15.39% |
Kabuuang sagutin | 105.92K | -66.95% |
Kabuuang equity | 4.15M | — |
Natitirang share | 45.51M | — |
Presyo para makapag-book | 6.33 | — |
Return on assets | -36.37% | — |
Return on capital | -38.06% | — |
Cash Flow
Net change in cash
| (CAD) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -656.86K | 37.71% |
Cash mula sa mga operasyon | -834.90K | 15.81% |
Cash mula sa pag-invest | — | — |
Cash mula sa financing | 7.00K | — |
Net change in cash | -823.21K | 18.57% |
Malayang cash flow | -601.65K | 3.22% |
Tungkol
Itinatag
2018
Headquarters
Website
